MedPath

Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone

Phase 3
Completed
Conditions
Type 2 Diabetes
Obesity
Interventions
Behavioral: Lifestyle modification
Registration Number
NCT00737347
Lead Sponsor
Northwestern University
Brief Summary

The purpose of the study is to investigate the effectiveness of three lifestyle treatment programs varying in level of intensiveness on prevention of pioglitazone-induced weight gain and to measure the composition of the change in body weight.

Detailed Description

The three lifestyle interventions were usual care (1 visit), standard care (4 total visits) and intensive care (10 total visits)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • type 2 diabetes with BMI 27 or greater, glycated hemoglobin 7% or greater
Exclusion Criteria
  • insulin treated

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
2.Lifestyle modificationStandard care. Subjects had 4 sessions with registered dietitian
3Lifestyle modificationIntensive care. subjects had 10 visits with registered dietitian
Primary Outcome Measures
NameTimeMethod
change in body weight24 weeks
Secondary Outcome Measures
NameTimeMethod
change in body composition24 weeks

Trial Locations

Locations (1)

Northwestern Memorial Hospital Wellness Institute

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath